AZD4547 [cytosol]

Stable Identifier
R-ALL-2038886
Type
ChemicalDrug
Compartment
Locations in the PathwayBrowser
General

AZD4547 (Astra Zeneca) is a pan-FGFR inhibitor in Phase I clinical trials for patients with advanced gastric cancer (NCT01457846) and for patient with advanced solid tumors with or without amplified FGFR1 or 2 (NCT00979134) and in Phase I/II trials for breast cancer patients with FGFR1 amplifications (NCT01202591).

External Reference Information
Participates
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
ChEBI
PharmacoDB
Cite Us!